On the 21st, employees of Innova, Humedix's Brazilian partner, and Brazilian medical staff visited the Pangyo headquarters. Provided by Humedix
Humedix, part of the Huons Group, announced on the 22nd that it held an on-site communication meeting by inviting its Brazilian partners and medical staff.
On the 21st, a total of 60 people, including employees of Humedix's Brazilian distribution partner Innova (INNOVA Pharma) and key local Brazilian medical staff, visited the Pangyo headquarters in Seongnam and the Jecheon factory.
In the morning, the foreign guests visited Humedix's Pangyo headquarters in Seongnam, toured the promotional hall, and listened to a corporate briefing on the Huons Group and Humedix. In the afternoon, they moved to Jecheon, where the Humedix factory is located, for a factory tour. The Brazilian delegation received explanations about the production of hyaluronic acid (HA) fillers exported to Brazil under strict production management and various representative products.
Innova, Humedix's Brazilian aesthetic medical distribution partner, is a company supplying aesthetic and medical products to hospitals and clinics throughout South America. Through strategic collaboration with global companies, it continues to grow in various areas, including aesthetic fillers, skin boosters, and medical devices. Innova collaborates with Humedix to launch and sell high-quality HA fillers in the Brazilian market. Humedix plans to increase the export items to Brazil and expand to other Latin American countries beyond Brazil.
Kang Min-jong, CEO of Humedix, stated, “We prepared the visit event to showcase our excellent competitiveness by inviting Brazilian medical staff and others who have a deep interest in Humedix products,” adding, “We will continue to maintain a close cooperative relationship with our partner Innova to consistently present excellent products in the Brazilian market.”
Ji Hee-su
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.